Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08KVZ
|
|||
| Former ID |
DAP000176
|
|||
| Drug Name |
Sibutramine
|
|||
| Synonyms |
Butramin; Medaria; Meridia; Reductil; Sibutramina; Sibutraminum; Sibutramina [Spanish]; Sibutraminum [Latin]; BTS-54524; Butramin (TN); Ectiva (TN); Meridia (TN); Reductil (TN); Sibutramine (INN); Sibutramine [INN:BAN]; N-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-N,N-dimethylamine HCl; 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Approved | [1], [2] | |
| Therapeutic Class |
Appetite Depressants
|
|||
| Company |
Abbott Laboratories
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H26ClN
|
|||
| Canonical SMILES |
CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
|
|||
| InChI |
1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3
|
|||
| InChIKey |
UNAANXDKBXWMLN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 106650-56-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9456, 3206268, 4368412, 7980597, 8153202, 11364918, 11367480, 11370042, 11372056, 11374791, 11378212, 11485348, 11489502, 11490824, 11492951, 11495775, 14750864, 29224267, 46387014, 46507740, 47509538, 47805058, 48416537, 49732001, 49816816, 49830262, 50064120, 50105677, 50474598, 57322655, 81040718, 85279508, 92308675, 92309273, 92714514, 93625048, 96025198, 103498411, 104308577, 108667174, 118048829, 121147434, 124659142, 124813324, 125311920, 125325628, 125337324, 126629463, 126655363, 126682940
|
|||
| ChEBI ID |
CHEBI:9137
|
|||
| ADReCS Drug ID | BADD_D02016 ; BADD_D02017 | |||
| SuperDrug ATC ID |
A08AA10
|
|||
| SuperDrug CAS ID |
cas=106650560
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Norepinephrine transporter (NET) | Target Info | Modulator | [3] |
| Serotonin transporter (SERT) | Target Info | Modulator | [3] | |
| KEGG Pathway | Serotonergic synapse | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
| 5HT1 type receptor mediated signaling pathway | ||||
| 5HT2 type receptor mediated signaling pathway | ||||
| 5HT3 type receptor mediated signaling pathway | ||||
| 5HT4 type receptor mediated signaling pathway | ||||
| Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
| WikiPathways | Monoamine Transport | |||
| NRF2 pathway | ||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
| SIDS Susceptibility Pathways | ||||
| Synaptic Vesicle Pathway | ||||
| Serotonin Transporter Activity | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2586). | |||
| REF 2 | Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.